Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents

Name: Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents
License: Public Domain

MedSIR

ClinicalTrials.gov · Datasets · License: Public Domain

metastatic thymic carcinoma, thymoma type b3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417533
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.